142 related articles for article (PubMed ID: 12207604)
1. Ferrochelatase gene polymorphism analysis for accurate genetic counselling in erythropoietic protoporphyria.
Morris SD; Mason NG; Elder GH; Hawk JL; Sarkany RP
Br J Dermatol; 2002 Sep; 147(3):572-4. PubMed ID: 12207604
[TBL] [Abstract][Full Text] [Related]
2. A new ferrochelatase mutation combined with low expression alleles in a Japanese patient with erythropoietic protoporphyria.
Yasui Y; Muranaka S; Tahara T; Shimizu R; Watanabe S; Horie Y; Nanba E; Uezato H; Takamiyagi A; Taketani S; Akagi R
Clin Sci (Lond); 2002 May; 102(5):501-6. PubMed ID: 11980567
[TBL] [Abstract][Full Text] [Related]
3. Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation.
Gouya L; Puy H; Lamoril J; Da Silva V; Grandchamp B; Nordmann Y; Deybach JC
Blood; 1999 Mar; 93(6):2105-10. PubMed ID: 10068685
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of the wild-type ferrochelatase allele is closely associated with severe liver complication in a family with erythropoietic protoporphyria.
Onaga Y; Ido A; Uto H; Hasuike S; Kusumoto K; Moriuchi A; Numata M; Nagata K; Hori T; Hayashi K; Tsubouchi H
Biochem Biophys Res Commun; 2004 Sep; 321(4):851-8. PubMed ID: 15358105
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of the molecular biology of erythropoietic protoporphyria.
Todd DJ
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):207-13. PubMed ID: 9883431
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele.
Gouya L; Deybach JC; Lamoril J; Da Silva V; Beaumont C; Grandchamp B; Nordmann Y
Am J Hum Genet; 1996 Feb; 58(2):292-9. PubMed ID: 8571955
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of erythropoietic protoporphyria.
Todd DJ
Photodermatol Photoimmunol Photomed; 1998 Apr; 14(2):70-3. PubMed ID: 9638728
[TBL] [Abstract][Full Text] [Related]
8. Human protoporphyria: genetic heterogeneity at the ferrochelatase locus.
Ostasiewicz LT; Huang JL; Wang X; Piomelli S; Poh-Fitzpatrick MB
Photodermatol Photoimmunol Photomed; 1995 Feb; 11(1):18-21. PubMed ID: 7654562
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation in the ferrochelatase gene associated with erythropoietic protoporphyria.
Imoto S; Tanizawa Y; Sato Y; Kaku K; Oka Y
Br J Haematol; 1996 Jul; 94(1):191-7. PubMed ID: 8757534
[TBL] [Abstract][Full Text] [Related]
10. New insights into the pathogenesis of erythropoietic protoporphyria and their impact on patient care.
Schneider-Yin X; Gouya L; Meier-Weinand A; Deybach JC; Minder EI
Eur J Pediatr; 2000 Oct; 159(10):719-25. PubMed ID: 11039124
[TBL] [Abstract][Full Text] [Related]
11. Haplotype analysis in determination of the heredity of erythropoietic protoporphyria among Swiss families.
Schneider-Yin X; Rüfenacht UB; Hergersberg M; Schnyder C; Deybach JC; Minder EI
J Invest Dermatol; 2001 Dec; 117(6):1521-5. PubMed ID: 11886517
[TBL] [Abstract][Full Text] [Related]
12. Haplotype analysis of families with erythropoietic protoporphyria and novel mutations of the ferrochelatase gene.
Wang X; Yang L; Kurtz L; Lichtin A; DeLeo VA; Bloomer J; Poh-Fitzpatrick MB
J Invest Dermatol; 1999 Jul; 113(1):87-92. PubMed ID: 10417624
[TBL] [Abstract][Full Text] [Related]
13. Modulation of penetrance by the wild-type allele in dominantly inherited erythropoietic protoporphyria and acute hepatic porphyrias.
Gouya L; Puy H; Robreau AM; Lyoumi S; Lamoril J; Da Silva V; Grandchamp B; Deybach JC
Hum Genet; 2004 Feb; 114(3):256-62. PubMed ID: 14669009
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietic protoporphyria (EPP) at 40. Where are we now?
Sarkany RP
Photodermatol Photoimmunol Photomed; 2002 Jun; 18(3):147-52. PubMed ID: 12207680
[TBL] [Abstract][Full Text] [Related]
15. Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria.
Rüfenacht UB; Gouya L; Schneider-Yin X; Puy H; Schäfer BW; Aquaron R; Nordmann Y; Minder EI; Deybach JC
Am J Hum Genet; 1998 Jun; 62(6):1341-52. PubMed ID: 9585598
[TBL] [Abstract][Full Text] [Related]
16. A "null allele" mutation is responsible for erythropoietic protoporphyria in an Israeli patient who underwent liver transplantation: relationships among biochemical, clinical, and genetic parameters.
Schoenfeld N; Mamet R; Minder EI; Schneider-Yin X
Blood Cells Mol Dis; 2003; 30(3):298-301. PubMed ID: 12737948
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of a ferrochelatase gene defect causing anomalous RNA splicing in erythropoietic protoporphyria.
Sarkany RP; Whitcombe DM; Cox TM
J Invest Dermatol; 1994 Apr; 102(4):481-4. PubMed ID: 8151124
[TBL] [Abstract][Full Text] [Related]
18. Molecular defect in human erythropoietic protoporphyria with fatal liver failure.
Nakahashi Y; Miyazaki H; Kadota Y; Naitoh Y; Inoue K; Yamamoto M; Hayashi N; Taketani S
Hum Genet; 1993 May; 91(4):303-6. PubMed ID: 8500787
[TBL] [Abstract][Full Text] [Related]
19. Genotypic determinants of phenotype in North American patients with erythropoietic protoporphyria.
Risheg H; Chen FP; Bloomer JR
Mol Genet Metab; 2003; 80(1-2):196-206. PubMed ID: 14567969
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietic protoporphyria: identification of novel mutations in the ferrochelatase gene and comparison of biochemical markers versus molecular analysis as diagnostic strategies.
Frank J; Nelson J; Wang X; Yang L; Ahmad W; Lam H; Jugert FK; Kalka K; Poh-Fitzpatrick MB; Goerz G; Merk HF; Christiano AM
J Investig Med; 1999 Jul; 47(6):278-84. PubMed ID: 10431482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
